-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S5gNhYicH3+OS4iW/82IOu79QZFhYx5aR75ZUJov2/Ruc6hi7f2sTz7FTIwnRFWK n6fniiqeOKAchziQAA1X8A== 0001179110-08-011536.txt : 20080605 0001179110-08-011536.hdr.sgml : 20080605 20080605211608 ACCESSION NUMBER: 0001179110-08-011536 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080604 FILED AS OF DATE: 20080605 DATE AS OF CHANGE: 20080605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncothyreon Inc. CENTRAL INDEX KEY: 0001412067 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 260868560 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 - 110TH AVENUE NE STREET 2: SUITE 685 CITY: BELLEVUE STATE: WA ZIP: 98004 BUSINESS PHONE: 425-450-0370 MAIL ADDRESS: STREET 1: 110 - 110TH AVENUE NE STREET 2: SUITE 685 CITY: BELLEVUE STATE: WA ZIP: 98004 FORMER COMPANY: FORMER CONFORMED NAME: Biomira CORP DATE OF NAME CHANGE: 20070911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taylor Edward A. CENTRAL INDEX KEY: 0001418876 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33882 FILM NUMBER: 08884233 BUSINESS ADDRESS: BUSINESS PHONE: (425) 450-0370 MAIL ADDRESS: STREET 1: 110 110TH AVENUE NE STREET 2: SUITE 685 CITY: BELLEVUE STATE: WA ZIP: 98004 4 1 edgar.xml FORM 4 - X0202 4 2008-06-04 0 0001412067 Oncothyreon Inc. ONTY 0001418876 Taylor Edward A. 2011 - 94 STREET SUITE 200 EDMONTON A0 T6N 1H1 ALBERTA, CANADA 0 1 0 0 CFO, VP Fin & Admin, Sec Stock Option (right to buy) 3.43 2008-06-04 4 A 0 10000 0 A 2016-06-04 Common Stock 10000 10000 D The option vests in four equal annual installments beginning on June 4, 2009. Barbara A. Mery, attorney-in-fact on behalf of Edward A. Taylor 2008-06-05 EX-24 2 ex24taylor.txt Power of Attorney The undersigned, as a Section 16 reporting person of Oncothyreon Inc. (the "Company"), hereby constitutes and appoints Wilson Sonsini Goodrich & Rosati, P.C. the undersigned's true and lawful attorney-in-fact to: 1. complete and execute Forms ID, 3, 4, and 5 and other forms and all amendments thereto as such attorney-in- fact shall in his or her discretion determine to be required or advisable pursuant to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned's ownership, acquisition or disposition of securities of the Company; and 2. do all acts necessary in order to file such forms with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other person or agency as the attorney-in-fact shall deem appropriate. The undersigned hereby ratifies and confirms all that said attorney-in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 (as amended). This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms ID, 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in- fact. In witness whereof, the undersigned has caused this Power of Attorney to be executed this 14th day of November, 2007. Signature: /s/ Edward A. Taylor Edward A. Taylor -----END PRIVACY-ENHANCED MESSAGE-----